VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+1.41%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$712M
AUM Growth
+$712M
(+43,807%)
Cap. Flow
-$653M
Cap. Flow
% of AUM
-91.83%
Top 10 Holdings %
Top 10 Hldgs %
6.85%
Holding
408
New
37
Increased
7
Reduced
332
Closed
32
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$9.68M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$2.06M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.87M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
$1.31M |
| 5 |
Signet Jewelers
SIG
|
$1.09M |
Top Sells
| 1 |
Amazon
AMZN
|
$15.2M |
| 2 |
Microsoft
MSFT
|
$7.69M |
| 3 |
Apple
AAPL
|
$6.46M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$5.45M |
| 5 |
Gilead Sciences
GILD
|
$5.09M |
Sector Composition
| 1 | Technology | 14.09% |
| 2 | Financials | 13.4% |
| 3 | Healthcare | 12.23% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
326
Agenus
AGEN
$133M
| $682K | 0.1% | 168,466 -152,712 | -48% | -$618K |
|
|
KDNY
327
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $682K | 0.1% | 60,298 +13,336 | +28% | +$151K |
|
328
Constellation Brands
STZ
$28.5B
| $680K | 0.1% | 4,111 -24,001 | -85% | -$3.97M |
|
|
ONC
329
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $678K | 0.1% | +22,751 | New | +$678K |
|
330
NVR
NVR
$22.4B
| $677K | 0.1% | 380 -894 | -70% | -$1.59M |
|
331
Cigna
CI
$80.3B
| $676K | 0.1% | 5,284 -8,832 | -63% | -$1.13M |
|
332
AB InBev
BUD
$122B
| $673K | 0.09% | +5,108 | New | +$673K |
|
|
CLLS
333
Cellectis
CLLS
$258M
| $672K | 0.09% | 25,254 -24,616 | -49% | -$655K |
|
334
Wave Life Sciences
WVE
$1.53B
| $669K | 0.09% | +32,332 | New | +$669K |
|
335
Sealed Air
SEE
$4.78B
| $665K | 0.09% | +14,466 | New | +$665K |
|
336
Credit Acceptance
CACC
$5.78B
| $661K | 0.09% | 3,569 -6,731 | -65% | -$1.25M |
|
337
Celldex Therapeutics
CLDX
$1.47B
| $661K | 0.09% | 150,643 +57,949 | +63% | +$254K |
|
338
Eagle Materials
EXP
$7.49B
| $660K | 0.09% | +8,553 | New | +$660K |
|
339
MKS Inc. Common Stock
MKSI
$6.94B
| $659K | 0.09% | 15,296 -8,684 | -36% | -$374K |
|
|
KITE
340
DELISTED
Kite Pharma, Inc.
KITE
| $657K | 0.09% | 13,147 -7,319 | -36% | -$366K |
|
341
Home Depot
HD
$405B
| $652K | 0.09% | 5,110 -11,668 | -70% | -$1.49M |
|
342
Lennar Class A
LEN
$34.5B
| $650K | 0.09% | 14,110 -30,458 | -68% | -$1.4M |
|
|
GTT
343
DELISTED
GTT Communications, Inc.
GTT
| $647K | 0.09% | 34,999 -98,801 | -74% | -$1.83M |
|
|
ADXS
344
DELISTED
Advaxis, Inc.
ADXS
| $646K | 0.09% | 79,843 -58,069 | -42% | -$470K |
|
345
Sabre
SABR
$706M
| $643K | 0.09% | +24,017 | New | +$643K |
|
346
Expedia Group
EXPE
$26.6B
| $641K | 0.09% | +6,030 | New | +$641K |
|
347
ImmunityBio
IBRX
$2.21B
| $638K | 0.09% | 102,500 +12,056 | +13% | +$75K |
|
348
Zimmer Biomet
ZBH
$21B
| $635K | 0.09% | +5,274 | New | +$635K |
|
349
General Dynamics
GD
$87.3B
| $632K | 0.09% | 4,542 -10,478 | -70% | -$1.46M |
|
350
Willis Towers Watson
WTW
$31.9B
| $631K | 0.09% | +5,080 | New | +$631K |
|